.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
Updates
With a single opinion from the U.S. Court of Appeals for the Federal Circuit, fraud just became more difficult to prove as part of the trademark application process. This week, the Federal Circuit released its long-awaited opinion in In re Bose Corp., Docket No. 2008-1448 (Fed. Cir. 2009) reversing the Trademark Trial and Appeal Board’s controversial Medinol standard for findings of fraud.
Click on the PDF link above to view the full alert.
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.